Patents by Inventor Nobuo Kondo

Nobuo Kondo has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrazole derivatives and diabetic medicine containing them
    Patent number: 7247616
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine
    Type: Grant
    Filed: October 24, 2005
    Date of Patent: July 24, 2007
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Benzene compounds
    Publication number: 20070105899
    Abstract: The present invention provides novel benzene compounds presented by the following formulas, and analogs thereof, that exert an ACC activity-inhibiting effect that is effective in the treatment of obesity, hyperlipemia, fatty liver, hyperglycemia, impaired glucose tolerance, diabetes, diabetic complications (diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, and diabetic macroangiopathy, hypertension, arteriosclerosis), hypertension, and arteriosclerosis.
    Type: Application
    Filed: October 13, 2006
    Publication date: May 10, 2007
    Inventors: Nobuyasu SUZUKI, Yukio Nihei, Hidehiro Ichinose, Hideyuki Tanaka, Noriko Yasa, Toshihiro Hatanaka, Yoko Masuzawa, Eiji Nakanishi, Nobuo Kondo
  • NEW PYRAZOLE DERIVATIVES AND DIABETIC MEDICINE CONTAINING THEM
    Publication number: 20070099979
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Application
    Filed: December 5, 2006
    Publication date: May 3, 2007
    Applicant: AJINOMOTO CO. INC
    Inventors: KOJI OHSUMI, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Lactam compounds and pharmaceutical use thereof
    Patent number: 7153850
    Abstract: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
    Type: Grant
    Filed: June 2, 2003
    Date of Patent: December 26, 2006
    Assignee: Ajinomoto Co., Inc.
    Inventors: Yukio Iino, Takao Ikenoue, Nobuo Kondo, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Masuzawa, Fumio Ohta, Akiyo Yamazaki, Seiji Niwa, Takashi Yamamoto
  • Fused polycyclic compounds having a heterocyclic ring(s) and pharmaceutical use thereof
    Publication number: 20060194789
    Abstract: The present invention provides a fused polycyclic compound of the following formula, analogues thereof and pharmaceutically acceptable salts thereof; and agents for increasing the sugar-transporting capacity, hypoglycemic agents and pharmaceutical compositions containing the above compounds. This fused polycyclic compound has high medicinal properties and few side-effects, and a therapeutic effect on diabetes. wherein R represents an alkoxy group, R? represents an oxazolylpropionyl group or a thiazolylpropionyl group, and R? represent a hydrogen atom.
    Type: Application
    Filed: May 1, 2006
    Publication date: August 31, 2006
    Applicant: Ajinomoto Co., Inc.
    Inventors: Ryusuke Hirama, Seiji Niwa, Hideyuki Tanaka, Toshihiro Hatanaka, Yoko Masuzawa, Akiyo Yamazaki, Takao Ikenoue, Nobuo Kondo, Wataru Miyanaga, Masaru Takayanagi
  • Lactam compounds and pharmaceutical use thereof
    Publication number: 20060189597
    Abstract: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
    Type: Application
    Filed: April 6, 2006
    Publication date: August 24, 2006
    Applicant: Ajinomoto Co., Inc.
    Inventors: Yukio Ilno, Takao Ikenoue, Nobuo Kondo, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Masuzawa, Fumio Ohta, Akiyo Yamazaki, Seiji Niwa, Takashi Yamamoto
  • Pyrazole derivatives and diabetic medicine containing them
    Patent number: 7015201
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Grant
    Filed: September 9, 2004
    Date of Patent: March 21, 2006
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • New pyrazole derivatives and diabetic medicine containing them
    Publication number: 20060058244
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Application
    Filed: October 24, 2005
    Publication date: March 16, 2006
    Applicant: AJINOMOTO CO. INC
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Therapeutic agents for diabetes
    Publication number: 20050272641
    Abstract: A pharmaceutical composition for preventing and/or treating diabetes, diabetic complication, hyperinsulinemia, disorders of glucose metabolism or obesity, comprising a combination of the following compound, analogues or pharmaceutically acceptable salts thereof with a hypoglycemic agent.
    Type: Application
    Filed: August 8, 2005
    Publication date: December 8, 2005
    Applicant: Ajinomoto Co., Inc.
    Inventors: Takao Ikenoue, Yoko Kageyama, Yukio Iino, Nobuo Kondo
  • Prophylactic and therapeutic agent of diabetes mellitus
    Publication number: 20050143424
    Abstract: The invention provides a prophylactic and therapeutic agent of diabetes mellitus, including a combination of an inhibitor of renal glucose reabsorption and a hypoglycemic agent. In accordance with the invention, hyperglycemia after meals, between meals and during fasting can be ameliorated. More specifically, in accordance with the invention, a therapeutic effect of diabetes mellitus as never been obtained by the hypoglycemic agents of the related art can be achieved.
    Type: Application
    Filed: October 26, 2004
    Publication date: June 30, 2005
    Applicant: AJINOMOTO CO. INC
    Inventors: Katsumi Maezono, Nozomu Ishida, Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Kageyama, Nobuo Kondo
  • N-substituted pyrazole-O-glycoside derivatives and therapeutic agent for diabetes containing the same
    Patent number: 6908905
    Abstract: The present invention relates to pyrazole derivatives represented by the following formulas and analogues thereof, which can be used for a therapeutic agent for diabetes.
    Type: Grant
    Filed: October 27, 2003
    Date of Patent: June 21, 2005
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Nozomu Ishida, Yoko Kageyama, Katsumi Maezono, Nobuo Kondo
  • New pyrazole derivatives and diabetic medicine containing them
    Publication number: 20050043249
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Application
    Filed: September 9, 2004
    Publication date: February 24, 2005
    Applicant: AJINOMOTO CO. INC
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Pyrazole derivatives and diabetic medicine containing them
    Patent number: 6815428
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Grant
    Filed: May 2, 2003
    Date of Patent: November 9, 2004
    Assignee: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • N-substituted pyrazole-O-glycoside derivatives and therapeutic agent for diabetes containing the same
    Publication number: 20040110936
    Abstract: The present invention relates to pyrazole derivatives represented by the following formulas and analogues thereof, which can be used for a therapeutic agent for diabetes.
    Type: Application
    Filed: October 27, 2003
    Publication date: June 10, 2004
    Applicant: Ajinomoto Co., Inc.
    Inventors: Koji Ohsumi, Hiroyuki Matsueda, Toshihiro Hatanaka, Nozomu Ishida, Yoko Kageyama, Katsumi Maezono, Nobuo Kondo
  • Lactam compounds and pharmaceutical use thereof
    Publication number: 20040048847
    Abstract: An agent for increasing the sugar-transporting capacity and an agent for preventing and/or treating diabetes, diabetic peripheral neuropathy, diabetic nephropathy, diabetic retinopathy, diabetic macroangiopathy, impaired glucose tolerance or adiposis, which contains a lactam compound or a pharmaceutically acceptable salt thereof as the active ingredient.
    Type: Application
    Filed: June 2, 2003
    Publication date: March 11, 2004
    Applicant: AJINOMOTO CO. INC
    Inventors: Yukio Iino, Takao Ikenoue, Nobuo Kondo, Hiroyuki Matsueda, Toshihiro Hatanaka, Ryusuke Hirama, Yoko Masuzawa, Fumio Ohta, Akiyo Yamazaki
  • Pyrazole derivatives and diabetic medicine containing them
    Publication number: 20040006025
    Abstract: The present invention provides pyrazole-O-glycoside derivatives represented by the following formulae, used as a diabetic medicine.
    Type: Application
    Filed: May 2, 2003
    Publication date: January 8, 2004
    Applicant: AJINOMOTO CO. INC
    Inventors: Koji Ohsumi, Takashi Umemura, Hiroyuki Matsueda, Toshihiro Hatanaka, Akiko Onuki, Katsumi Maezono, Yoko Kageyama, Nobuo Kondo
  • Composition for oral administration containing pyridazinone compounds
    Patent number: 5942249
    Abstract: A composition for oral administration which contains a pyridazinone compound of the formula (I) ##STR1## wherein R.sup.1, R.sup.2 and R.sup.3 are each independently a hydrogen atom or a lower alkyl, X is a halogen atom, a cyano or a hydrogen atom, Y is a halogen atom, a trifluoromethyl or a hydrogen atom, and A is a C.sub.1 -C.sub.8 alkylene optionally substituted by hydroxy, or a pharmacologically acceptable salt thereof, and an organic acid. According to the present invention, a composition for oral administration which is stable to heat, light, moisture and the like and which shows improved dissolution and absorption of a pyridazinone compound can be provided.
    Type: Grant
    Filed: January 28, 1998
    Date of Patent: August 24, 1999
    Assignees: The Green Cross Corporation, Nissan Chemical Industries, Ltd.
    Inventors: Toru Iwao, Tomoyo Seki, Nobuo Kondo, Yasuo Ueda
  • Benzoyl urea compound-albumin complex
    Patent number: 5116949
    Abstract: A benzoyl urea compound-albumin complex comprising a benzoyl urea compound of the formula: ##STR1## wherein X is a halogen atom or a nitro group, Y is a hydrogen atom, a halogen atom, a nitro group or a trifluoromethyl group, Z.sub.1 is a halogen atom or a trifluoromethyl group, Z.sub.2 is a hydrogen atom or a halogen atom and A is CH or a nitrogen atom, and albumin.
    Type: Grant
    Filed: August 31, 1989
    Date of Patent: May 26, 1992
    Assignees: Ishihara Sangyo Kaisha Ltd., The Green Cross Corporation
    Inventors: Tsunetaka Nakajima, Tadao Okamoto, Nobuo Kondo, Masahiro Watanabe, Koichi Yamauchi, Kazumasa Yokoyama, Takahiro Haga, Nobutoshi Yamada, Hideo Sugi, Toru Koyanagi
  • Powdery pharmaceutical composition containing benzoyl urea, a dispersant and silicic acid
    Patent number: 5098907
    Abstract: A powdery pharmaceutical composition comprising a benzoyl urea compound of the formula: ##STR1## wherein X is a halogen atom or a nitro group, Y is a hydrogen atom, a halogen atom, a nitro group or a trifluoromethyl group, Z.sub.1 is a halogen atom or a trifluoromethyl group, Z.sub.2 is a hydrogen atom or a halogen atom, and A is CH or a nitrogen atom, as an active ingredient, a nonionic surfactant as a dispersant, at least one member selected from the group consisting of sugar, sugar-alcohol and a nonionic surfactant as a disintegrant, and anhydrous silicic acid as a fluidizer.
    Type: Grant
    Filed: January 23, 1990
    Date of Patent: March 24, 1992
    Assignees: Ishihara Sangyo Kaisha Ltd., The Green Cross Corporation
    Inventors: Nobuo Kondo, Masahiro Kikuchi, Tsunetaka Nakajima, Masahiro Watanabe, Kouichi Yamauchi, Takahiro Haga, Nobutoshi Yamada, Hideo Sugi, Toru Koyanagi
  • Readily absorbed pharmaceutical composition
    Patent number: 5002952
    Abstract: A pharmaceutical composition comprising a benzoyl urea compound having the formula: ##STR1## wherein X is a halogen atom or a nitro group, Y is a hydrogen atom, a halogen atom, a nitro group or a trifluoromethyl group, Z.sub.1 is a halogen atom or a trifluoromethyl group, Z.sub.2 is a hydrogen atom or a halogen atom, and A is a .dbd.CH--group or a nitrogen atom, and a nonionic surfactant.
    Type: Grant
    Filed: July 27, 1989
    Date of Patent: March 26, 1991
    Assignees: Ishihara Sangyo Kaisha Ltd., The Green Cross Corporation
    Inventors: Nobuo Kondo, Tsunetaka Nakajima, Masahiro Watanabe, Kazumasa Yokoyama, Takahiro Haga, Nobutoshi Yamada, Hideo Sugi, Toru Koyanagi